Naz E. Wehrli, Ph.D. is a registered patent attorney and a member of the Litigation Department in Fried Frank's New York office. She joined the Firm in 2012.
Dr. Wehrli's practice is concentrated in the field of intellectual property, including patent and trademark litigation. Her patent litigation practice focuses on the chemical, pharmaceutical, and biotechnological fields, and medical and other devices. Recently, Dr. Wehrli assisted in a trial before the District Court pursuant to 35 U.S.C. § 145 challenging a reissue determination on the validity of an issued US patent.
Prior to joining Fried Frank, Dr. Wehrli was an Assistant Professor in the Department of Molecular & Medical Genetics at Oregon Health Sciences University (OHSU). The primary focuses of Dr. Wehrli's research were hereditary nonpolyposis colorectal cancer and DNA mismatch repair, using yeast and mammalian cells as model systems. She also has considerable experience in genetics, molecular biology and cell biology. Prior to joining the faculty of OHSU, Dr. Wehrli was a post-doctoral fellow in the Department of Molecular & Medical Genetics at OHSU from 2001-2006, and in the Department of Molecular Biology at Princeton University, New Jersey from 1998-2001. Dr. Wehrli was also a lecturer in the Department of Molecular Biology at Princeton University and taught molecular biology to undergraduates.
Dr. Wehrli has authored or co-authored numerous articles in peer-reviewed journals. While in academics, she received grant support from the National Institutes of Health, the Medical Research Foundation and the OHSU Cancer Institute.